Editorial
doi: 10.1016/j.drudis.2019.07.012.
Epub 2019 Sep 6.
Learning and augmenting natural processes: potential means of combating antimicrobial resistance from a drug R&D perspective
Affiliations
- PMID: 31499189
- DOI: 10.1016/j.drudis.2019.07.012
Item in Clipboard
Editorial
Learning and augmenting natural processes: potential means of combating antimicrobial resistance from a drug R&D perspective
Drug Discov Today.
2020 Jan.
No abstract available
Similar articles
-
Omics of antimicrobials and antimicrobial resistance.Expert Opin Drug Discov. 2019 May;14(5):455-468. doi: 10.1080/17460441.2019.1588880. Epub 2019 Mar 19. Expert Opin Drug Discov. 2019. PMID: 30884978 Review.
-
Research councils unite to tackle antimicrobial resistance.Vet Rec. 2014 Jul 26;175(4):79. doi: 10.1136/vr.g4722. Vet Rec. 2014. PMID: 25059955 No abstract available.
-
Resisting antimicrobial resistance.Nat Rev Microbiol. 2020 May;18(5):259-260. doi: 10.1038/s41579-020-0348-5. Nat Rev Microbiol. 2020. PMID: 32300248 No abstract available.
-
Antimicrobial stewardship: a proactive approach to combating resistance.JAAPA. 2012 Feb;25(2):22, 26. doi: 10.1097/01720610-201202000-00004. JAAPA. 2012. PMID: 22416550 No abstract available.
-
Phytotherapy as an alternative to conventional antimicrobials: combating microbial resistance.Expert Rev Clin Pharmacol. 2017 Nov;10(11):1203-1214. doi: 10.1080/17512433.2017.1371591. Epub 2017 Aug 31. Expert Rev Clin Pharmacol. 2017. PMID: 28836870 Review.
Cited by
-
Prediction of tissue exposures of polymyxin-B, amikacin and sulbactam using physiologically-based pharmacokinetic modeling.Front Microbiol. 2024 Oct 7;15:1435906. doi: 10.3389/fmicb.2024.1435906. eCollection 2024. Front Microbiol. 2024. PMID: 39435440 Free PMC article.
-
Predicting the correct dose in children: Role of computational Pediatric Physiological-based pharmacokinetics modeling tools.CPT Pharmacometrics Syst Pharmacol. 2023 Jan;12(1):13-26. doi: 10.1002/psp4.12883. Epub 2022 Nov 20. CPT Pharmacometrics Syst Pharmacol. 2023. PMID: 36330677 Free PMC article. Review.
-
Metabolomics unveil key pathways underlying the synergistic activities of aztreonam and avibactam against multidrug-resistant Escherichia coli.Eur J Clin Microbiol Infect Dis. 2024 Jul;43(7):1393-1405. doi: 10.1007/s10096-024-04837-4. Epub 2024 May 9. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38722450
-
Metabolomics revealed mechanism for the synergistic effect of sulbactam, polymyxin-B and amikacin combination against Acinetobacter baumannii.Front Microbiol. 2023 Jun 29;14:1217270. doi: 10.3389/fmicb.2023.1217270. eCollection 2023. Front Microbiol. 2023. PMID: 37455727 Free PMC article.
-
Comparative metabolomics reveal key pathways associated with the synergistic activities of aztreonam and clavulanate combination against multidrug-resistant Escherichia coli.mSystems. 2023 Dec 21;8(6):e0075823. doi: 10.1128/msystems.00758-23. Epub 2023 Oct 13. mSystems. 2023. PMID: 37830827 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
